Quince Therapeutics Inc.

QNCX | NASDAQ

Price Alert Chart Builder DCF Calculator

$31.81

+$0.81 (+2.61%)

Sep 22, 2026, 11:24 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	142K	n/a	n/a	n/a	n/a	n/a
Gross Profit	-142K	n/a	n/a	n/a	n/a	n/a
Operating Income	-50.43M	-57.29M	-34.62M	-52.02M	-90.32M	-78.89M
Interest Income	1.24M	2.93M	3.48M	1.07M	620K	2.04M
Pretax Income	-80.77M	-56.74M	-31.58M	-51.94M	-89.95M	-76.85M
Net Income	-83.98M	-56.83M	-31.39M	-51.66M	-89.95M	-76.85M
Selling & General & Admin	15.05M	17.58M	17.7M	26.01M	29.52M	17.59M
Research & Development	35.38M	18.59M	9.45M	25.18M	60.8M	61.31M
Other Expenses	-142K	21.12M	7.48M	825K	n/a	n/a
Operating Expenses	50.29M	57.29M	34.62M	52.02M	90.32M	78.89M
Interest Expense	n/a	n/a	n/a	568K	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	50.43M	57.29M	34.62M	52.02M	90.32M	78.89M
Income Tax Expense	3.21M	87K	-197K	-284K	n/a	n/a
Shares Outstanding (Basic)	250.49K	216.31K	186.19K	167.48K	148.59K	145.88K
Shares Outstanding (Diluted)	250.49K	216.31K	186.19K	167.48K	148.59K	145.88K
EPS (Basic)	-336	-262	-168	-308	-606	-526
EPS (Diluted)	-336	-262	-168	-308	-606	-526
EBITDA	-80.62M	-35.98M	-26.82M	-50.99M	-89.6M	-78.56M
EBIT	-80.77M	-36.17M	-27.14M	-51.19M	-89.95M	-78.89M
Depreciation & Amortization	142K	186K	322K	204K	344K	332K